Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Ocular Oncology
•
Ophthalmology
•
Cornea and External Disease
How do you determine the role of adjunctive therapies for a patient with conjunctival squamous cell carcinoma (SCC) that has recurred after initial surgical excision?
Related Questions
How do you decide on treatment modality for ocular surface squamous neoplasia?
How do you approach the management of a patient with a small, indeterminate choroidal mass with no obvious primary malignancy?
How do you approach IOL calculations and selection in patients with keratoconus based on disease severity?
What alternative treatments are available for refractory filamentary keratitis in a patient for whom bandage contact lenses provide the only relief and who has failed cyclosporine and N-acetylcysteine drops?
How do you approach IOL exchange in a patient who is unhappy after cataract surgery with a premium IOL?
What factors influence your decision to pursue surgical management in cases of infectious keratitis caused by multidrug-resistant pathogens?
What is your approach to incorporating IPL therapy for meibomian gland dysfunction?
How do you manage a twice-recurrent mucinous adenocarcinoma of the lower eyelid with direct involvement of the lateral rectus muscle and lacrimal duct?
What factors influence the decision to initiate anti-VEGF injections to prevent radiation retinopathy after plaque brachytherapy?
What is the appropriate interval before safely performing cataract surgery after plaque radiation therapy for iris melanoma?
